Four researchers from Boston have individually been able to receive three years worth grant in which they will be able to test transformational research questions for prostate cancer sufferers.

The Prostate Cancer Foundation found that the beneficiaries were among this year’s 21 new Young Investigator Awardees. This was the charity foundation’s attempt to help the eminent researchers at pioneering cancer centers throughout the United States and Canada.

This year’s awards had been designed to motivate young researchers to keep their focus on prostate cancer, which totaled to $4.5 million.

Every award comprises of $225,000 from the charity house, which is coordinated by the recipients’ research organizations, doubling it to $450,000. Including this year’s honorees, the organization is now giving financial support to
43 research projects internationally.

Howard R. Soule, the Executive Vice President and Chief Science Officer for the PCF said that the organization was making investments in the careers of the world’s best researchers so that they can discover improved treatments for prostate cancer.

It is found in the research that men with prostate cancer are more prone to develop blood lumps, particularly if they are undergoing hormone therapy.